News

Glenmark launches new pump packs for OTC Adapalene Gel in US

The Differin Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million

  • By IPP Bureau | October 06, 2026

Glenmark Therapeutics Inc. USA has introduced its over-the-counter (OTC) Adapalene Gel USP, 0.1% in a brand-new pump-pack format. This product features the same active ingredient and strength found in Differin Gel, 0.1%.

According to Nielsen syndicated data for the latest 52-week period ending September 5, 2026, the Differin Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million.

Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, "The introduction of Adapalene Gel USP, 0.1% (OTC) in a new pump pack enhances consumer experience by offering a convenient and easy to use dispensing option while further strengthening our growing U.S. dermatology portfolio. This launch reflects our commitment to delivering high quality and affordable healthcare solutions that meet evolving consumer needs."

Upcoming E-conference

Other Related stories

Startup

Digitization

Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
(L-R) Manoj Kumar Panicker, General Manager, South Asia, Cytiva and Dr. Sanjib Banerjee, Chief Operating Officer (Biopharma Services), Veeda Lifesciences.